Again, the decision about which candidates we should place our bets on was guided by the advice of the experts on the vaccine task force. They do include a Canadian company, partly because the Canadian company had promised, but also because to your point, having a biomanufacturing capacity in Canada is important. This is a way we can support that development, and that is the Medicago company based in Montreal. Again, we have an option on 76 million doses from that candidate.
